A detailed history of Wells Fargo & Company transactions in Absci Corp stock. As of the latest transaction made, Wells Fargo & Company holds 30,979 shares of ABSI stock, worth $97,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,979
Previous 31,270 0.93%
Holding current value
$97,583
Previous $96,000 22.92%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.97 - $4.49 $864 - $1,306
-291 Reduced 0.93%
30,979 $118,000
Q2 2024

Aug 13, 2024

BUY
$2.92 - $6.58 $89,865 - $202,506
30,776 Added 6229.96%
31,270 $96,000
Q1 2024

May 10, 2024

SELL
$3.41 - $5.74 $37,990 - $63,949
-11,141 Reduced 95.75%
494 $2,000
Q4 2023

Feb 09, 2024

SELL
$1.15 - $4.79 $177,035 - $737,391
-153,944 Reduced 92.97%
11,635 $48,000
Q3 2023

Nov 13, 2023

BUY
$1.28 - $2.41 $7,257 - $13,664
5,670 Added 3.55%
165,579 $218,000
Q2 2023

Aug 15, 2023

BUY
$1.17 - $2.03 $600 - $1,041
513 Added 0.32%
159,909 $243,000
Q1 2023

May 12, 2023

BUY
$1.58 - $3.41 $37,528 - $80,994
23,752 Added 17.51%
159,396 $278,000
Q4 2022

Feb 13, 2023

SELL
$2.0 - $3.58 $96,786 - $173,246
-48,393 Reduced 26.3%
135,644 $284,000
Q3 2022

Nov 14, 2022

BUY
$2.95 - $4.83 $535,690 - $877,079
181,590 Added 7420.92%
184,037 $576,000
Q2 2022

Aug 12, 2022

SELL
$3.13 - $8.83 $102,363 - $288,776
-32,704 Reduced 93.04%
2,447 $8,000
Q1 2022

May 16, 2022

BUY
$5.87 - $9.46 $108,600 - $175,019
18,501 Added 111.12%
35,151 $296,000
Q4 2021

Feb 14, 2022

BUY
$7.88 - $18.03 $115,725 - $264,788
14,686 Added 747.76%
16,650 $136,000
Q3 2021

Nov 15, 2021

BUY
$10.37 - $30.29 $20,366 - $59,489
1,964 New
1,964 $23,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $292M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.